Dr. John Charlson and his patient Megan joined us to help educate viewers on Synovial Sarcoma, early diagnosis and how to find a treatment center. Synovial sarcoma, a life-threatening cancer, ...

Tecelra is the first engineered cell therapy for the treatment of certain patients with advanced synovial sarcoma. One year ...

KUTV — July is Sarcoma Awareness Month, a time to raise understanding about rare cancers like synovial sarcoma—a life-threatening soft tissue cancer that often appears as a painful lump near the knee, ...

Cell therapies first reached patients as treatments for blood cancers. Adaptimmune Therapeutics’ work in this therapeutic modality has culminated in an FDA nod in synovial sarcoma, a regulatory ...

A collaborative research team, led by scientists at VCU Massey Comprehensive Cancer Center and Huntsman Cancer Institute at ...

The probability of overall survival after 1, 5, and 10 years was predicted by a nomogram model, which found that worse Surveillance, Epidemiology, and End Results (SEER) stage was associated with ...

Patients with advanced synovial sarcoma may have a new therapy option if the novel drug, afami-cel, is approved by the FDA after the priority review. The Food and Drug Administration (FDA) has ...

The US Food and Drug Administration has approved afamitresgene autoleucel (afami-cel) (Tecelra, Adaptimmune LLC) to treat advanced synovial sarcoma. Afami-cel — the first engineered cell therapy for a ...

Randomized Phase II Study of Docetaxel Versus Doxorubicin in First- and Second-Line Chemotherapy for Locally Advanced or Metastatic Soft Tissue Sarcomas in Adults: A Study of the European Organization ...

Use of histologic and immunologic factors in sarcoma to predict response rates to immunotherapy. A phase II study of an oncolytic herpes simplex virus 2 and an anti-PD-1 antibody in patients with ...